BioSpace News Archive

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, is pleased to announce that the United States Federal Food and Drug Agency (“FDA”) has approved a supplemental Investigational Device Exemption (“IDE”) for the use of Spectral’s PMX cartridge (“PMX”) in the treatment of patients with COVID-19.

Antengene announced today that it has dosed the first patient in Taiwan , China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and tolerability of ATG-019 monotherapy or ATG-019 combined with niacin ER (vita

DiNovA Medtech, the leading medical devices incubator in China (“DiNovA”, or the “Company”), is pleased to announce Vivek Y. Reddy, MD to join as Chief Medical Advisor and Cofounder of portfolio company Nuomao Medtech (“Nuomao”) to lead cardiac arrhythmia related innovations.

GNS Healthcare is pleased to announce that Dr. Earl Steinberg, a nationally recognized expert in population health management, data analytics, and clinical informatics, has joined the company’s leadership team as a consultant to advance the company’s health plan offerings and drive clinical analytics efforts across GNS, particularly within biopharma market-access and value-based drug collaborations between biopharma and payers..

Surveillance Data Demonstrates Nationwide Prevalence of Antibiotic Resistant Bacteria Common in Eye Infections

Medical communications agency AlphaBioCom has appointed Laura LeGower, MBA, CMPP, as Senior Vice President and Head of Client Services.

Impulse Dynamics, a medical device company dedicated to improving the lives of heart failure patients, today announced the publication of the FIX-HF-5C2 study in Circulation: Heart Failure.

Iodine, known for its potent antibacterial effects, has been in use in a variety of formulations, particularly to disinfect skin and mucosa

Cancer informatics and digital pathology solution provider Inspirata announced earlier this week its free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19

Lumiata uses artificial intelligence to address the cost and risk of healthcare for customers.